# OnCo record interpath-001 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/interpath-001/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "interpath-001", "NCT05933577" ;
  schema:name "INTerpath-001 (V940-001)"@en ;
  schema:description "INTerpath-001 was the first positive phase 3 trial of a personalised cancer vaccine, announced 19 August 2026."@en ;
  schema:url <https://onco.cc/trials/interpath-001/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05933577>, <https://www.merck.com/news/merck-and-moderna-announce-phase-3-interpath-001-trial-of-intismeran-autogene-plus-keytruda-met-endpoints-of-recurrence-free-survival-rfs-and-distant-metastasis-free-survival-dmfs-in-patient/> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2023-07-19" ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/stage-iii-melanoma/>, <https://onco.cc/cancers/stage-ii-melanoma/> ;
  onco:technologies <https://onco.cc/technologies/neoantigen-mrna-vaccine/> ;
  onco:drugs <https://onco.cc/drugs/intismeran-autogene/>, <https://onco.cc/drugs/pembrolizumab/> ;
  onco:companies <https://onco.cc/companies/moderna/> ;
  onco:people <https://onco.cc/people/jeffrey-weber/> .